Literature DB >> 12223467

The N termini of focal adhesion kinase family members regulate substrate phosphorylation, localization, and cell morphology.

Jill M Dunty1, Michael D Schaller.   

Abstract

The focal adhesion kinase (FAK) and cell adhesion kinase beta (CAKbeta, PYK2, CADTK, RAFTK) are highly homologous FAK family members, yet clearly have unique roles in the cell. Comparative analyses of FAK and CAKbeta have revealed intriguing differences in their activities. These differences were investigated further through the characterization of a set of FAK/CAKbeta chimeric kinases. CAKbeta exhibited greater catalytic activity than FAK in vitro, providing a molecular basis for differential substrate phosphorylation by FAK and CAKbeta in vivo. Furthermore, the N terminus may regulate catalytic activity since chimeras containing the FAK N terminus and CAKbeta catalytic domain exhibited a striking high level of catalytic activity and substrate phosphorylation. Unexpectedly, a modulatory role for the N termini in subcellular localization was also revealed. Chimeras containing the FAK N terminus and CAKbeta C terminus localized to focal adhesions, whereas chimeras containing the N and C termini of CAKbeta did not. Finally, prominent changes in cell morphology were induced upon expression of chimeras containing the CAKbeta N terminus, which were not associated with apoptotic cell death, cell cycle progression delay, or changes in Rho activity. These results demonstrate novel regulatory roles for the N terminus of FAK family kinases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12223467     DOI: 10.1074/jbc.M201779200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  FERM domain interaction promotes FAK signaling.

Authors:  Jill M Dunty; Veronica Gabarra-Niecko; Michelle L King; Derek F J Ceccarelli; Michael J Eck; Michael D Schaller
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

2.  FERM domain interaction with myosin negatively regulates FAK in cardiomyocyte hypertrophy.

Authors:  Aline M Santos; Deborah Schechtman; Alisson C Cardoso; Carolina F M Z Clemente; Júlio C Silva; Mariana Fioramonte; Michelle B M Pereira; Talita M Marin; Paulo S L Oliveira; Ana Carolina M Figueira; Saulo H P Oliveira; Íris L Torriani; Fábio C Gozzo; José Xavier Neto; Kleber G Franchini
Journal:  Nat Chem Biol       Date:  2011-11-20       Impact factor: 15.040

Review 3.  The FERM domain: organizing the structure and function of FAK.

Authors:  Margaret C Frame; Hitesh Patel; Bryan Serrels; Daniel Lietha; Michael J Eck
Journal:  Nat Rev Mol Cell Biol       Date:  2010-11       Impact factor: 94.444

4.  The Pyk2 FERM regulates Pyk2 complex formation and phosphorylation.

Authors:  Daniel Riggs; Zhongbo Yang; Jean Kloss; Joseph C Loftus
Journal:  Cell Signal       Date:  2010-09-16       Impact factor: 4.315

Review 5.  Targeting Pyk2 for therapeutic intervention.

Authors:  Christopher A Lipinski; Joseph C Loftus
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

6.  Structural conservation in band 4.1, ezrin, radixin, moesin (FERM) domains as a guide to identify inhibitors of the proline-rich tyrosine kinase 2.

Authors:  Nathalie Meurice; Lei Wang; Christopher A Lipinski; Zhongbo Yang; Christopher Hulme; Joseph C Loftus
Journal:  J Med Chem       Date:  2010-01-28       Impact factor: 7.446

Review 7.  FERM control of FAK function: implications for cancer therapy.

Authors:  Ssang-Taek Lim; David Mikolon; Dwayne G Stupack; David D Schlaepfer
Journal:  Cell Cycle       Date:  2008-05-29       Impact factor: 4.534

8.  Differential effects of Pyk2 and FAK on the hypertrophic response of cardiac myocytes.

Authors:  Emmanuel B Menashi; Joseph C Loftus
Journal:  Cell Tissue Res       Date:  2009-05-12       Impact factor: 5.249

9.  The Pyk2 FERM domain as a target to inhibit glioma migration.

Authors:  Joseph C Loftus; Zhongbo Yang; Nhan L Tran; Jean Kloss; Carole Viso; Michael E Berens; Christopher A Lipinski
Journal:  Mol Cancer Ther       Date:  2009-06-09       Impact factor: 6.261

10.  Postsynaptic clustering and activation of Pyk2 by PSD-95.

Authors:  Jason A Bartos; Jason D Ulrich; Hongbin Li; Michael A Beazely; Yucui Chen; John F Macdonald; Johannes W Hell
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.